300 related articles for article (PubMed ID: 10690382)
21. Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors.
Elkins G; Marcus J; Stearns V; Perfect M; Rajab MH; Ruud C; Palamara L; Keith T
J Clin Oncol; 2008 Nov; 26(31):5022-6. PubMed ID: 18809612
[TBL] [Abstract][Full Text] [Related]
22. Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine.
Loprinzi CL; Flynn PJ; Carpenter LA; Atherton P; Barton DL; Shanafelt TD; Rummans TA; Sloan JA; Adjei AA; Mincey BA; Fitch TR; Collins M
J Palliat Med; 2005 Oct; 8(5):924-30. PubMed ID: 16238505
[TBL] [Abstract][Full Text] [Related]
23. Evaluation and Comparison of Citalopram and Venlafaxine for Management of Hot Flashes in Women with Breast Cancer.
Taleghani SY; Etesam F; Esfandbod M
Drug Res (Stuttg); 2023 Oct; 73(8):465-472. PubMed ID: 37647930
[TBL] [Abstract][Full Text] [Related]
24. Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women.
Stubbs C; Mattingly L; Crawford SA; Wickersham EA; Brockhaus JL; McCarthy LH
J Okla State Med Assoc; 2017 May; 110(5):272-274. PubMed ID: 28649145
[TBL] [Abstract][Full Text] [Related]
25. Yoga of Awareness program for menopausal symptoms in breast cancer survivors: results from a randomized trial.
Carson JW; Carson KM; Porter LS; Keefe FJ; Seewaldt VL
Support Care Cancer; 2009 Oct; 17(10):1301-9. PubMed ID: 19214594
[TBL] [Abstract][Full Text] [Related]
26. Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors.
Bordeleau L; Pritchard KI; Loprinzi CL; Ennis M; Jugovic O; Warr D; Haq R; Goodwin PJ
J Clin Oncol; 2010 Dec; 28(35):5147-52. PubMed ID: 21060031
[TBL] [Abstract][Full Text] [Related]
27. Comparison of citalopram and venlafaxine's role in treating sleep disturbances in menopausal women, a randomized, double-blind, placebo-controlled trial.
Davari-Tanha F; Soleymani-Farsani M; Asadi M; Shariat M; Shirazi M; Hadizadeh H
Arch Gynecol Obstet; 2016 May; 293(5):1007-13. PubMed ID: 26437957
[TBL] [Abstract][Full Text] [Related]
28. Bupropion for control of hot flashes in breast cancer survivors: a prospective, double-blind, randomized, crossover, pilot phase II trial.
Nuñez GR; Pinczowski H; Zanellato R; Tateyama L; Schindler F; Fonseca F; Del Giglio A
J Pain Symptom Manage; 2013 Jun; 45(6):969-79. PubMed ID: 23017618
[TBL] [Abstract][Full Text] [Related]
29. Hot flashes and related outcomes in breast cancer survivors and matched comparison women.
Carpenter JS; Johnson D; Wagner L; Andrykowski M
Oncol Nurs Forum; 2002 Apr; 29(3):E16-25. PubMed ID: 11979290
[TBL] [Abstract][Full Text] [Related]
30. Pilot evaluation of hypnosis for the treatment of hot flashes in breast cancer survivors.
Elkins G; Marcus J; Stearns V; Hasan Rajab M
Psychooncology; 2007 May; 16(5):487-92. PubMed ID: 17048223
[TBL] [Abstract][Full Text] [Related]
31. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis.
Nelson HD; Vesco KK; Haney E; Fu R; Nedrow A; Miller J; Nicolaidis C; Walker M; Humphrey L
JAMA; 2006 May; 295(17):2057-71. PubMed ID: 16670414
[TBL] [Abstract][Full Text] [Related]
32. Hot flashes in breast cancer survivors: Frequency, severity and impact.
Chang HY; Jotwani AC; Lai YH; Jensen MP; Syrjala KL; Fann JR; Gralow J
Breast; 2016 Jun; 27():116-21. PubMed ID: 27065357
[TBL] [Abstract][Full Text] [Related]
33. Effects of Hypericum perforatum (St. John's wort) on hot flashes and quality of life in perimenopausal women: a randomized pilot trial.
Al-Akoum M; Maunsell E; Verreault R; Provencher L; Otis H; Dodin S
Menopause; 2009; 16(2):307-14. PubMed ID: 19194342
[TBL] [Abstract][Full Text] [Related]
34. Paroxetine (Brisdelle) for hot flashes.
Med Lett Drugs Ther; 2013 Oct; 55(1428):85-6. PubMed ID: 24165707
[No Abstract] [Full Text] [Related]
35. Pilot evaluation of selective serotonin reuptake inhibitor antidepressants in hot flash patients under androgen-deprivation therapy for prostate cancer.
Naoe M; Ogawa Y; Shichijo T; Fuji K; Fukagai T; Yoshida H
Prostate Cancer Prostatic Dis; 2006; 9(3):275-8. PubMed ID: 16786037
[TBL] [Abstract][Full Text] [Related]
36. Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study.
Loibl S; Schwedler K; von Minckwitz G; Strohmeier R; Mehta KM; Kaufmann M
Ann Oncol; 2007 Apr; 18(4):689-93. PubMed ID: 17229772
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.
Trivedi MH; Pigotti TA; Perera P; Dillingham KE; Carfagno ML; Pitts CD
J Clin Psychiatry; 2004 Oct; 65(10):1356-64. PubMed ID: 15491239
[TBL] [Abstract][Full Text] [Related]
38. Effects of stellate-ganglion block on hot flushes and night awakenings in survivors of breast cancer: a pilot study.
Lipov EG; Joshi JR; Sanders S; Wilcox K; Lipov S; Xie H; Maganini R; Slavin K
Lancet Oncol; 2008 Jun; 9(6):523-32. PubMed ID: 18485819
[TBL] [Abstract][Full Text] [Related]
39. Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes.
Carpenter JS; Elam JL; Ridner SH; Carney PH; Cherry GJ; Cucullu HL
Oncol Nurs Forum; 2004 May; 31(3):591-5598. PubMed ID: 15146224
[TBL] [Abstract][Full Text] [Related]
40. Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.
Loprinzi CL; Levitt R; Barton D; Sloan JA; Dakhil SR; Nikcevich DA; Bearden JD; Mailliard JA; Tschetter LK; Fitch TR; Kugler JW
J Clin Oncol; 2006 Mar; 24(9):1409-14. PubMed ID: 16505409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
